Komori
Governance197ATAUNS Laboratories,Inc.Pharmaceuticals

Articles of Incorporation 2026/09/25

The articles of incorporation were amended on 25 September 2026. However, the specific changes from the previous version are not set out in the text.

Worth reading
85Important
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Governance structure

Company with an Audit and Supervisory Committee
Number of directorsUp to 9 (up to 4 directors who are not Audit & Supervisory Committee members and up to 5 directors who are Audit & Supervisory Committee members). The number of outside directors is not stated.
Committee1
Audit and Supervisory Committee
Percentage of outside members the proportion of outside members is not stated
Changes this time

Amended on 25 September 2026. The specific changes from the previous articles of incorporation are not stated.

Governance structure
ItemDetails
Corporate Governance StructureCompany with an Audit and Supervisory Committee
Number of directorsUp to 9 (up to 4 directors who are not Audit & Supervisory Committee members and up to 5 directors who are Audit & Supervisory Committee members). The number of outside directors is not stated.
CommitteeAudit and Supervisory Committee (the proportion of outside members is not stated)
Changes this timeAmended on 25 September 2026. The specific changes from the previous articles of incorporation are not stated.
Items this document does not state (4)
Number of independent officersPolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

No reason for the amendment is stated.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Articles of Incorporation 2026/09/25 | TAUNS Laboratories,Inc. (197A) timely disclosure | Komori